Phase 4 N=37 Assessment and Augmentation of Lip Appearance in Specific Study Populations
Lip Aging · Lip Augmentation · Lip
Primary: Change in Lip Vessel's Thickness — 0.833; 0.360 µm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=273 New Dermal Filler for Lip Augmentation
Lip Augmentation
Primary: Assess Effectiveness of the Treatment Using the Medicis Lip Fullness Scale (MLFS) — 1.8; 1.7; 1.8; 1.8 Change in MLFS score from baseline
N/A N=213 Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation
Lip Augmentation
Primary: Percentage of Subjects With ≥1-Point Improvement on the Investigator Assessed 5-point Lip Fullness Scale 2 (LFS2) — 79.1; 26.1 Percentage of Subjects
N/A N=180 Safety/Efficacy Study of Restylane® in Lip Augmentation
Lip Augmentation
Primary: Percentage of Participants With Response — 92.6; 28.9 Percentage of Participants
N/A N=20 Perioral Rejuvenation and Upper Lip Enhancement
Perioral Rejuvenation · Upper Lip Projection
Primary: Nasal Tip Projection — 0.601 ratio
Phase 4 N=60 A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation
Lip Augmentation
Primary: Percentage of Participants With a ≥ 1-point Improvement (Increase) in the Lip Fullness Scale (LFS2) Compared to Baseline Assessment at Day 30 — 93.2 percentage of…
N/A N=158 Safety and Effectiveness of PN40082 for Lip Augmentation
Lip Augmentation
Primary: Change in Overall Lip Fullness Grading Scale — 1.52; 1.53 score on a scale
N/A N=62 Safety and Effectiveness of Juvéderm® Ultra Lip Injectable Gel for Lip Enhancement
Lip Enhancement
Primary: Investigator Assessment of the Subject's Overall Lip Fullness on the 4-point Lip Fullness Scale — 93.2 percentage of responders
N/A N=281 Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement
Lip Volume Enhancement
Primary: Month 3 Overall Lip Fullness Scale Responder Rate Based on Independent Central Reviewer's Assessment — 34.1; 29.3 Percentage of subjects
N/A N=114 Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation
Abnormal Lip
Primary: Responder Rate in Lip Volume Improvement — 55; 52; 107; 53 Participants
N/A N=176 Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults
Lip Enhancement
Primary: Percentage of Participants With a ≥1-point Increase (Improvement) on the Evaluating Investigator's (EI's) Assessed 5-point Lip Fullness Scale (LFS) — 0; 84.7 percentage…
Phase 3 N=84 A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation
Lip Augmentation
Primary: Change From Baseline in Lip Fullness Grading Scale — .82 score on a scale
N/A N=60 Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation
Lip Augmentation and Correction of Perioral Rhytids
Primary: Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine — 11 Participants
N/A N=225 A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement
Subjects Desiring Lip Augmentation
Primary: Change From Baseline in Evaluating Investigator's Assessment of Lip Fullness on a 5-Point Scale — 1.2; 1.1; 1.1; 1.0 Scores on a Scale
N/A N=62 Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips
Lip Augmentation
Primary: Subject Rating of the Natural Look and Feel of the Lips — 52.5; 35.6; 11.9; 0 Percentage of subjects
N/A N=22 Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects
Lip Augmentation
Primary: Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on Medicis Lip Fullness Scale (MLFS) — 94.7; 94.7 percentage of participants
N/A N=202 RHA® 3 Versus Restylane-L® for Lip Augmentation
Lip Augmentation · Lip
Primary: Change in TLFS Score (Teoxane Lip Fullness Scale) Between Baseline and Week 12 After Last Treatment of RHA®3 Versus Control Device, as Assessed by the BLE — 1.0; 0.8…
N/A N=29 JUVÉDERM VOLUMA® to Enhance the Appearance of the Asian Nose
Asian Nose Enhancement
Primary: Percentage of Participants With a ≥ 1 Grade Improvement on the Assessment of Aesthetic Improvement Scale (AAIS) as Assessed by the Central Evaluating Physician at Day…
N/A N=20 Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions
Lip Rejuvenation
Primary: First Impressions — 46.756; 27.769; 46.391; 34.404 score on a scale
N/A N=60 Study to Evaluate Efficacy, Safety and Injection Technique of Restylane Lip Volume and Restylane Lip Refresh
Injection Techniques
Primary: GEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 8 After Treatment — 86.2; 86.7 percentage improved subjects
N/A N=192 A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation
Chin Retrusion
Primary: Percentage of Participants With a ≥ 1-point Improvement (Decrease) on the Allergan Chin Retrusion Scale (ACSR) Score — 56.3; 27.5 percentage of participants — p=0.0019
N/A N=20 (Macrolane VR30) in Buttocks Reshaping and contouringCellulite (Macrolane VR30) in Buttocks Reshaping and Contouring
Cellulite of the Buttocks
Primary: Number of Patients With Aesthetic Improvement of the Buttocks Using Investigator GAIS — 7 Participants
Phase 4 N=58 Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour
Contour
Primary: Percentage of Participants Who Showed ≥ 1-point Jawline Improvement From Baseline on the Allergan Loss of Jawline Definition Scale (ALJDS), as Assessed by the…
N/A N=60 Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation
Cheek Augmentation · Midface Contour Deficiencies
Primary: Number of Participants With Treatment-Emergent Adverse Events [Safety] — 5 Participants
N/A N=100 Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population
Healthy Volunteers
Primary: Percentage of Participants Improved in "Global Facial Aesthetic Appearance" - Judged by Participant — 95 percentage of participants
N/A N=115 The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face
Age-related Volume Deficit in the Mid-face
Primary: Subject Experience Measured by Patient Satisfaction Questionnaire — 1.94; 1.62; 1.51 Units on a scale
N/A N=62 Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
Nasolabial Fold, Hypoplastic
Primary: NLF-SRS Grade of Nasolabial Folds Change — -1.50 score on a scale
N/A N=270 GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Cheek Augmentation
Primary: Assess Efficacy of Study Treatment Using Medicis Midface Volume Score (MMVS) — -1.4; -0.1; -1.3 score on a scale
N/A N=110 Saypha® Volume LIdocaine in Nasolabial Folds
Moderate to Severe Nasolabial Folds
Primary: Responder Rate in Reduction of Nasolabial Folds — 34; 39; 73 Participants
N/A N=16 Jowl Improvement With Injectable Fillers
Jowls
Primary: Blinded Physician Jawline Rating Scale (JRS) Assessment on Scale of 0 to 4 at Baseline Versus 4 Weeks After Last Injection. — 2.214; 2.071; 1.857; 1.857 score on a scale…